|
Volumn 18, Issue 3, 2004, Pages 589-591
|
Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase.
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;
ANTIOXIDANT;
DEXTROMETHORPHAN;
DOPAMINE;
NERVE PROTEIN;
NEUROPROTECTIVE AGENT;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;
ANIMAL;
ARTICLE;
C57BL MOUSE;
CELL CULTURE;
CHEMICALLY INDUCED DISORDER;
COCULTURE;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG SCREENING;
METABOLISM;
MOUSE;
NERVE CELL;
OXIDATIVE STRESS;
PARKINSONISM;
PATHOLOGY;
SUBSTANTIA NIGRA;
1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE;
ANIMALS;
ANTIOXIDANTS;
CELLS, CULTURED;
COCULTURE TECHNIQUES;
DEXTROMETHORPHAN;
DOPAMINE;
DRUG EVALUATION, PRECLINICAL;
MICE;
MICE, INBRED C57BL;
NADPH OXIDASE;
NERVE TISSUE PROTEINS;
NEURONS;
NEUROPROTECTIVE AGENTS;
OXIDATIVE STRESS;
PARKINSONIAN DISORDERS;
SUBSTANTIA NIGRA;
|
EID: 2442693172
PISSN: None
EISSN: 15306860
Source Type: Journal
DOI: 10.1096/fj.03-0983fje Document Type: Article |
Times cited : (182)
|
References (0)
|